FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:829-830 August 23, 2007 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: Recent studies have shown a poor prognosis for patients with heart failure who have a normal ejection fraction,¹ a finding that differs markedly from the results of randomized, controlled trials.^2,3 This discrepancy requires an explanation.

Many patients with heart failure who have serious, common coexisting illnesses, such as pulmonary disease, atrial fibrillation, and renal dysfunction (all of which are both markers and mediators of a worse outcome), are excluded from randomized, controlled trials for two obvious reasons. First, heart failure with a normal ejection fraction is largely a diagnosis of exclusion, and patients with coexisting illnesses are . . . [Full Text of this Article]

This article has been cited by other articles:

• Cleland, J. G., McMurray, J. J.V., Kjekshus, J., Cornel, J. H., Dunselman, P., Fonseca, C., Hjalmarson, A., Korewicki, J., Lindberg, M., Ranjith, N., van Veldhuisen, D. J., Waagstein, F., Wedel, H., Wikstrand, J., on behalf of the CORONA Study Group, (2009). Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).. J Am Coll Cardiol 54: 1850-1859 [Abstract] [Full Text]  
• Farkas, J., Nabb, S., Zaletel-Kragelj, L., Cleland, J. G.F., Lainscak, M. (2009). Self-rated health and mortality in patients with chronic heart failure. Eur J Heart Fail 11: 518-524 [Abstract] [Full Text]  
• Metra, M., Dei Cas, L., Massie, B. M. (2009). Treatment of heart failure in the elderly: never say it's too late. Eur Heart J 30: 391-393 [Full Text]  
• Tang, W.H. W., Francis, G. S. (2008). The Year in Heart Failure. J Am Coll Cardiol 52: 1671-1678 [Full Text]  
• Maisel, A., Mueller, C., Adams, K. Jr., Anker, S. D., Aspromonte, N., Cleland, J. G.F., Cohen-Solal, A., Dahlstrom, U., DeMaria, A., Di Somma, S., Filippatos, G. S., Fonarow, G. C., Jourdain, P., Komajda, M., Liu, P. P., McDonagh, T., McDonald, K., Mebazaa, A., Nieminen, M. S., Peacock, W. F., Tubaro, M., Valle, R., Vanderhyden, M., Yancy, C. W., Zannad, F., Braunwald, E. (2008). State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10: 824-839 [Abstract] [Full Text]  
• Betteridge, D. J., DeFronzo, R. A., Chilton, R. J. (2008). PROactive: time for a critical appraisal. Eur Heart J 29: 969-983 [Abstract] [Full Text]  
• McMurray, J. J.V., Carson, P. E., Komajda, M., McKelvie, R., Zile, M. R., Ptaszynska, A., Staiger, C., Donovan, J. M., Massie, B. M. (2008). Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail 10: 149-156 [Abstract] [Full Text]